Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regulatory effects of hemp seed/evening primrose oil supplement in comparison with rapamycin on the expression of the mammalian target of rapamycin-complex 2 and interleukin-10 genes in experimental autoimmune encephalomyelitis.
Rezapour-Firouzi S, Kheradmand F, Shahabi S, Tehrani AA, Mazloomi E, Mohammadzadeh A. Rezapour-Firouzi S, et al. Among authors: mohammadzadeh a. Res Pharm Sci. 2019 Feb;14(1):36-45. doi: 10.4103/1735-5362.251851. Res Pharm Sci. 2019. PMID: 30936931 Free PMC article.
STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance.
Gharibi T, Barpour N, Hosseini A, Mohammadzadeh A, Marofi F, Ebrahimi-Kalan A, Nejati-Koshki K, Abdollahpour-Alitappeh M, Safaei S, Baghbani E, Baradaran B. Gharibi T, et al. Among authors: mohammadzadeh a. Int Immunopharmacol. 2023 Jun;119:110160. doi: 10.1016/j.intimp.2023.110160. Epub 2023 Apr 18. Int Immunopharmacol. 2023. PMID: 37080068
Corrigendum to "STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance" [Int. Immunopharmacol. 119 (2023) 110160].
Gharibi T, Barpour N, Hosseini A, Mohammadzadeh A, Marofi F, Ebrahimi-Kalan A, Nejati-Koshki K, Abdollahpour-Alitappeh M, Safaei S, Baghbani E, Baradaran B. Gharibi T, et al. Among authors: mohammadzadeh a. Int Immunopharmacol. 2023 Jun;119:110303. doi: 10.1016/j.intimp.2023.110303. Epub 2023 May 11. Int Immunopharmacol. 2023. PMID: 37179201 No abstract available.
277 results